A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Qilu Pharmaceutical Co., Ltd.
Arcus Biosciences, Inc.
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Merck Sharp & Dohme LLC
Eli Lilly and Company
Sanofi